Treatment of pain
Patent 6511982 Issued on January 28, 2003. Estimated Expiration Date: 
January 4, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
January 4, 2021. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.Patent ReferencesBuspirone anti-anxiety method Quinoline derivatives which are 5-hydroxytryptamine antagonists Quinoline derivatives Quinoline derivatives which are 5-hydroxytryptamine antagonists Acetaminophen/hydroxyzine analgesic combinations Formulation of 5-HT agonist and NSAID for treatment of migraine Patent #: 5872145 InventorsAssigneeApplicationNo. 754766 filed on 01/04/2001US Classes:514/252.15, Spiro ring system containing514/922SIDE EFFECT REDUCTION BY INCORPORATION OF A SECOND DESIGNATED INGREDIENTExaminersPrimary: Krass, FrederickAttorney, Agent or FirmForeign Patent References
International ClassA61K 031/497Foreign Application Priority Data1999-06-30 FRAbstractA method of treating pain with acetaminophen comprises the concurrent administration of buspirone. This combination of agents surprisingly results in a morphine-like analgesic response characterized by rapid onset, greater pain relief, and a longer duration of action.Other References
| |
